US Stock MarketDetailed Quotes

Connect Biopharma (CNTB)

Watchlist
  • 2.380
  • -0.100-4.03%
Close May 15 16:00 ET
  • 2.380
  • 0.0000.00%
Post 20:01 ET
149.85MMarket Cap-2.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Connect Biopharma (CNTB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
169K
-99.75%64K
0
-98.69%16K
-99.80%48K
0
26.03M
698K
1.22M
24.12M
Operating revenue
--169K
-99.75%64K
--0
-98.69%16K
-99.80%48K
--0
--26.03M
--698K
--1.22M
--24.12M
Cost of revenue
Gross profit
Operating expense
72.76%19.78M
19.91%58.14M
50.49%15.53M
17.44%17.69M
28.67%13.47M
-9.39%11.45M
-29.79%48.49M
10.32M
15.07M
10.47M
Selling and administrative expenses
-1.41%4.75M
5.78%20.34M
3.99%4.24M
8.70%6.58M
-8.26%4.7M
21.26%4.81M
19.78%19.23M
--4.08M
--6.06M
--5.12M
-General and administrative expense
-1.41%4.75M
5.78%20.34M
3.99%4.24M
8.70%6.58M
-8.26%4.7M
21.26%4.81M
19.78%19.23M
--4.08M
--6.06M
--5.12M
Research and development costs
126.59%15.03M
29.20%37.8M
80.92%11.28M
23.32%11.11M
64.04%8.77M
-23.43%6.63M
-44.80%29.26M
--6.24M
--9.01M
--5.35M
Operating profit
-71.29%-19.61M
-158.66%-58.07M
-61.41%-15.53M
-27.67%-17.68M
-198.37%-13.42M
9.39%-11.45M
67.49%-22.45M
-9.62M
-13.85M
13.65M
Net non-operating interest income expense
-63.89%260K
-49.07%2.27M
-54.77%384K
-51.98%545K
-49.35%619K
-42.26%720K
-14.74%4.45M
849K
1.14M
1.22M
Non-operating interest income
-63.89%260K
-49.07%2.27M
-54.77%384K
-51.98%545K
-49.35%619K
-42.26%720K
-14.74%4.45M
--849K
--1.14M
--1.22M
Other net income (expense)
-100.59%-3K
-79.84%523K
300.00%60K
93.52%-7K
-533.33%-39K
-81.31%509K
40.44%2.59M
-30K
-108K
9K
Other non- operating income (expenses)
-100.59%-3K
-79.84%523K
300.00%60K
93.52%-7K
-533.33%-39K
-81.31%509K
40.44%2.59M
---30K
---108K
--9K
Income before tax
-89.37%-19.35M
-258.86%-55.28M
-71.39%-15.08M
-33.70%-17.14M
-186.33%-12.84M
-17.95%-10.22M
75.15%-15.41M
-8.8M
-12.82M
14.88M
Income tax
-11.11%48K
-11.66%197K
-74.53%27K
7.02%61K
83.33%55K
80.00%54K
85.83%223K
106K
57K
30K
Net income
-88.84%-19.4M
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
-8.91M
-12.88M
14.85M
Net income continuous Operations
-88.84%-19.4M
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
---8.91M
---12.88M
--14.85M
Minority interest income
Net income attributable to the parent company
-88.84%-19.4M
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
-8.91M
-12.88M
14.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-88.84%-19.4M
-255.00%-55.48M
-69.65%-15.11M
-33.58%-17.2M
-186.88%-12.9M
-18.16%-10.27M
74.84%-15.63M
-8.91M
-12.88M
14.85M
Basic earnings per share
-78.95%-0.34
-257.14%-1
-68.75%-0.27
-34.78%-0.31
-185.19%-0.23
-18.75%-0.19
75.22%-0.28
-0.16
-0.23
0.27
Diluted earnings per share
-78.95%-0.34
-257.14%-1
-68.75%-0.27
-34.78%-0.31
-185.19%-0.23
-18.75%-0.19
75.22%-0.28
-0.16
-0.23
0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 169K-99.75%64K0-98.69%16K-99.80%48K026.03M698K1.22M24.12M
Operating revenue --169K-99.75%64K--0-98.69%16K-99.80%48K--0--26.03M--698K--1.22M--24.12M
Cost of revenue
Gross profit
Operating expense 72.76%19.78M19.91%58.14M50.49%15.53M17.44%17.69M28.67%13.47M-9.39%11.45M-29.79%48.49M10.32M15.07M10.47M
Selling and administrative expenses -1.41%4.75M5.78%20.34M3.99%4.24M8.70%6.58M-8.26%4.7M21.26%4.81M19.78%19.23M--4.08M--6.06M--5.12M
-General and administrative expense -1.41%4.75M5.78%20.34M3.99%4.24M8.70%6.58M-8.26%4.7M21.26%4.81M19.78%19.23M--4.08M--6.06M--5.12M
Research and development costs 126.59%15.03M29.20%37.8M80.92%11.28M23.32%11.11M64.04%8.77M-23.43%6.63M-44.80%29.26M--6.24M--9.01M--5.35M
Operating profit -71.29%-19.61M-158.66%-58.07M-61.41%-15.53M-27.67%-17.68M-198.37%-13.42M9.39%-11.45M67.49%-22.45M-9.62M-13.85M13.65M
Net non-operating interest income expense -63.89%260K-49.07%2.27M-54.77%384K-51.98%545K-49.35%619K-42.26%720K-14.74%4.45M849K1.14M1.22M
Non-operating interest income -63.89%260K-49.07%2.27M-54.77%384K-51.98%545K-49.35%619K-42.26%720K-14.74%4.45M--849K--1.14M--1.22M
Other net income (expense) -100.59%-3K-79.84%523K300.00%60K93.52%-7K-533.33%-39K-81.31%509K40.44%2.59M-30K-108K9K
Other non- operating income (expenses) -100.59%-3K-79.84%523K300.00%60K93.52%-7K-533.33%-39K-81.31%509K40.44%2.59M---30K---108K--9K
Income before tax -89.37%-19.35M-258.86%-55.28M-71.39%-15.08M-33.70%-17.14M-186.33%-12.84M-17.95%-10.22M75.15%-15.41M-8.8M-12.82M14.88M
Income tax -11.11%48K-11.66%197K-74.53%27K7.02%61K83.33%55K80.00%54K85.83%223K106K57K30K
Net income -88.84%-19.4M-255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M-8.91M-12.88M14.85M
Net income continuous Operations -88.84%-19.4M-255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M---8.91M---12.88M--14.85M
Minority interest income
Net income attributable to the parent company -88.84%-19.4M-255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M-8.91M-12.88M14.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -88.84%-19.4M-255.00%-55.48M-69.65%-15.11M-33.58%-17.2M-186.88%-12.9M-18.16%-10.27M74.84%-15.63M-8.91M-12.88M14.85M
Basic earnings per share -78.95%-0.34-257.14%-1-68.75%-0.27-34.78%-0.31-185.19%-0.23-18.75%-0.1975.22%-0.28-0.16-0.230.27
Diluted earnings per share -78.95%-0.34-257.14%-1-68.75%-0.27-34.78%-0.31-185.19%-0.23-18.75%-0.1975.22%-0.28-0.16-0.230.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -